1. Introduction {#sec1}
===============

Free radicals are harmful by-product of cellular oxidative phosphorylation and energy production. These radicals damage various intracellular macromolecules to include DNA, protein, and lipids \[[@B15]\]. Antioxidants have the ability to prevent oxidative damage and inhibit inflammatory conditions by nullifying the activities of free radicals \[[@B20]\]. Currently, the search for plant sources of antioxidants is gaining momentum with*Clausena excavata* (Rutaceae family) among the plants targeted.*C. excavata* is a medicinal plant widely distributed in Southeast Asia and is known by unique local names, such as Chamat in Thailand and Jia huang pi in China. In Malaysia the plant is locally known as "Cherek hitam" and "Kemantu hitam." The leaves of the plant are used in folklore medicine for the treatment of several illnesses such as malaria, headache, abdominal pain, dysentery, pulmonary tuberculosis, diarrhoea, cold, wound, snake-bite, and poisoning. Recent studies showed that the plant also possessed immune-modulatory \[[@B25]\], analgesic \[[@B35]\], anti-inflammatory, antivirus, anticancer \[[@B31]\], antioxidant \[[@B12]\], antimycobacterial \[[@B41]\], and antifungal \[[@B22]\] activities.*C. excavata* has been reported to exhibit one of the highest beneficial biological activities among*Clausena* genus \[[@B2]\]. These activities are attributed to its high phenolic compounds such as furanocoumarins and flavonoids. The plant also contains other pharmacologically active compounds like coumarin, carbazole alkaloid, and flavonoid glycosides \[[@B41], [@B23]--[@B46]\].

It is imperative that compounds from plants for human use are screened for potential toxicity, particularly for repeated and prolonged applications. Toxicity following overdose of active principles from plant candidates poses limitations to its use, since it may result in deaths in some cases \[[@B39]\]. Although a recent study reported that repeated oral doses of the methanol extract of*C. excavata*stem \[[@B34]\] did not cause significant pathological changes in rats, there is currently a paucity of information on the safe use of the plant leaves. This present study aims to determine the antioxidant properties and the safety of oral application of methanol extract of*C. excavata*leaves in rats.

2. Materials and Methods {#sec2}
========================

2.1. Collection, Identification, and Processing of Plant Material {#sec2.1}
-----------------------------------------------------------------

*C. excavata* leaves were collected from Pendang, Kedah, Malaysia. The plant was identified and authenticated by Dr. Shamsul Khamis of the Biodiversity Unit, Institute of Bioscience, Universiti Putra Malaysia. The leaves were sorted, washed, and dried at room temperature for two weeks before being grinded into powder and stored in air tight plastic bags.

2.2. Extraction of Plant Material {#sec2.2}
---------------------------------

Extraction was done at room temperature using petroleum ether, chloroform, ethyl acetate, and methanol in succession. The extraction at a 1 : 5 dried plant weight to volume ratio began with petroleum ether for 3 days. The filtrate was collected and the residues were subject to further extraction with chloroform, ethyl acetate, and methanol, and the filtrate was collected after each solvent extraction. All filtrates were evaporated to dry under reduced pressure using rotary evaporator at 45 to 50°C to obtain crude extracts.

2.3. *In Vitro* Assessment of Antioxidant Activity {#sec2.3}
--------------------------------------------------

### 2.3.1. 2,2-Diphenyl-1-picryl Dyhydrazyl Free Radical Scavenging Method {#sec2.3.1}

DPPH scavenging activity of*C. excavata* petroleum ether, chloroform, ethyl acetate, and methanol extracts were estimated using the method of Lim and Murtijaya \[[@B24]\] and Alnajar et al. \[[@B49]\]. Briefly, 195 *μ*L DPPH reagent was added to 5 *μ*L of samples or quercetin standard. The mixtures were vigorously shaken and incubated in the dark for 2 hours at room temperature. Absorbance reading was done using a spectrophotometer at 515 nm against a blank.

### 2.3.2. Ferric Reducing Antioxidant Power Assay Method {#sec2.3.2}

Ferric-reducing antioxidant power (FRAP) of each fraction was estimated according to the method of Alnajar et al. \[[@B49]\] and Mayakrishnan et al. \[[@B27]\]. Briefly, the freshly prepared reaction mixture containing 25 mL of acetate buffer, 2.5 mL of 2,4,6-Tripyridyl-s-Triazine (TPTZ) solution and 2.5 mL of FeCl~3~ *·*6H~2~O was incubated for 5 minutes at 37°C water-bath and absorbance was measured using a spectrophotometer at 593 nm. Thirty microliter of extract and ninety microliter of distilled water were added to nine hundred microliters of FRAP working reagent and mixed before absorbance was measured at 593 nm.

### 2.3.3. Total Phenol Content {#sec2.3.3}

The total phenol content (TPC) of each fraction was determined as described earlier using Folin-Ciocalteu reagent and Gallic acid as a standard \[[@B49], [@B26]\]. Absorbance was measured spectrophotometrically at 750 nm and results were expressed as mg Gallic acid equivalent (GAE) per g of extract (mg GAE/g).

### 2.3.4. Total Flavonoid Content {#sec2.3.4}

Total flavonoid was estimated using the method developed by Adedapo et al. \[[@B1]\]. Briefly, 0.5 mL of the sample was added to 0.5 mL of 2% AlCl~3~ dissolved in ethanol. After incubation for one hour at room temperature, the absorbance was measured at 420 nm. A calibration curve was prepared using (+) quercetin equivalent per gram (QE/g) extract.

### 2.3.5. Phytochemical Characterization of the Methanolic Extract of*C. excavata* {#sec2.3.5}

The LC-MS/MS analysis was carried out as described earlier by Mayakrishnan et al. \[[@B26]\], using an AB Sciex 3200 Q trap with Perkin Elmer UHPLC FX15.

2.4. Experimental Animals {#sec2.4}
-------------------------

Thirty-six adult male and female Sprague-Dawley rats, 8 to 10 weeks old, weighing between 165 and 200 g, were procured from the Animal House of the Faculty of Medicine, University of Malaya, Malaysia. The rats were maintained in clean stainless steel cages at an ambient temperature of 25 ± 2°C and fed standard rat/mouse pellet (Specialty Feeds, Glen Forrest, Western Australia) and water*ad libitum*for one week before experimentation. All studies performed were approved by the Institutional Animal Care and Use Committee, University of Malaya (ISB/22/007/2013/1111/SFA).

### 2.4.1. Animal Grouping and Acute Oral Toxicity Study {#sec2.4.1}

The Animals were subdivided into 2 groups, males (*n* = 16) and females (*n* = 16). The groups were designated as control male (CM), control female (CF), given 10% Tween-20 orally, and treatment groups, administered extract orally as follows: male 1 (M1, 2000 mg/kg body weight extract), male 2 (M2, 5000 mg/kg body weight extract), female 1 (F1, 2000 mg/kg body weight extract), and female 2 (F2, 5000 mg/kg body weight extract). The acute oral toxicity of the methanolic extract*C. excavata* (MECE) leaves was evaluated following Organization for Economic Cooperation and Development (OECD-423) guidelines \[[@B33]\] with slight modification. The M1 and F1 rats were each administered one dose of 2000 mg/kg orally and M2 and F2 rats were administered 5000 mg/kg body weight of the extract suspended in 10% Tween-20 (5 mL/kg). The rats were monitored for mortality for 48 hours and humanely euthanized after 14 days.

### 2.4.2. Blood Parameters {#sec2.4.2}

The rats were fasted overnight with free access to water. Blood samples were collected in plain and EDTA coated tubes. Serum was separated by centrifugation of whole clotted blood at 3000 r/min (Hettich, EBA 20) for 10 minutes and used to determine concentrations of alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, bilirubin, creatinine (Cr), urea (BUN), sodium (Na^+^), potassium (K^+^), and chloride (Cl^−^). Non-coagulated blood samples collected in EDTA tubes were used for hematological evaluation; red blood cell count (RBC), hemoglobin (Hb) concentration, and white blood cell count (WBC).

2.5. Histopathology {#sec2.5}
-------------------

All the rats were humanely sacrificed and the gross pathology of internal organs was evaluated. Tissue samples of the liver and kidney were collected from all the experimental groups, weighed, and then fixed in 10% buffered formalin. The fixed tissues were embedded, sectioned, and stained with hematoxylin and eosin stain and observed under light microscopy.

2.6. Statistical Analyses {#sec2.6}
-------------------------

All data obtained from this study were analysed using SPSS computer statistical software package, version 19, and expressed as mean ± standard deviation (SD). Significance within groups was determined using one-way ANOVA and Tukey\'s posttest analysis at *P* \< 0.05 for significance.

3. Results {#sec3}
==========

Extraction of air-dried ground*C. excavata* leaves with petroleum ether, chloroform, ethyl acetate, and methanol produces extract yield (wt/wt) of 1.56, 2.57, 0.38, and 0.94%, respectively.

3.1. Ferric Reducing Antioxidant Power {#sec3.1}
--------------------------------------

The increase in FRAP absorption suggested that the extract has free radical scavenging properties. The study showed that methanolic and ethyl acetate extracts at 3 mg/mL possessed the highest antioxidant activity ([Figure 1](#fig1){ref-type="fig"}).

3.2. DPPH Free Radical Scavenging of*Clausena excavata*Extracts {#sec3.2}
---------------------------------------------------------------

The DPPH radical scavenging activities of different extracts of*C. excavata* leaves are presented in [Figure 2](#fig2){ref-type="fig"}. The study showed that the methanolic extract possessed the highest radical scavenging activity.

3.3. Total Phenolic and Flavonoid Contents of*Clausena excavata* Extracts {#sec3.3}
-------------------------------------------------------------------------

[Table 1](#tab1){ref-type="table"} shows the phenolic and flavonoid content of the different crude leave extracts. The MECE leaves had the highest amount of phenolic compounds, while the chloroform extract had the highest total flavonoid content.

3.4. Phytochemical Characterization of the Methanolic Extract of*C. excavata* {#sec3.4}
-----------------------------------------------------------------------------

Based on LCMS/MS analysis, the MECE contains pipecolic acid, myricetin glucoside conjugate, quercetin-rhamnose-hexose-rhamnose, kaempferol conjugate, phenolic acid, flavonoids, furocoumarin, and 8-geranyloxy psoralen ([Table 2](#tab2){ref-type="table"}).

3.5. Acute Oral Toxicity Study {#sec3.5}
------------------------------

There were no mortality or behavioural abnormality in rats treated orally with 2000 and 5000 mg/kg body weight of the methanolic fraction of the plant extract showing that the oral LD50 of MECE leaves was greater than 5000 mg/kg body weight. Metabolic studies showed that body weight was lower in the group treated with high doses of extract. The kidneys and liver of rats treated with the extract did not show gain in relative organ weights ([Table 3](#tab3){ref-type="table"}).

3.6. Serum Biochemistry and Hematology {#sec3.6}
--------------------------------------

### 3.6.1. Liver Function Test {#sec3.6.1}

The liver function tests showed slightly increased serum enzyme concentrations in both male and female rats fed MECE leaves. M2 had elevated serum ALP, AST, and ALT concentrations, while in F2, only the ALT and ALP concentration increased slightly (*P* \< 0.05). Total serum bilirubin concentration increased in both F1 and F2 rats ([Table 4](#tab4){ref-type="table"}).

### 3.6.2. Renal Function Test {#sec3.6.2}

Serum creatinine concentrations of M1 and M2 rats were significantly (*P* \< 0.05) lower than that of NC male rats. However, the BUN concentration of the M2 rats were not significantly (*P* \> 0.05) different from that of the control. The mean BUN concentration of F2 rats was significantly (*P* \< 0.05) higher than that of control by 24%. Similarly, serum Na^+^, K^+^, and Cl^−^ concentrations were variably elevated among the male and female treatment groups ([Table 5](#tab5){ref-type="table"}).

### 3.6.3. Hematological Parameters {#sec3.6.3}

The erythrocyte and leukocyte counts and Hb concentration did not significantly (*P* \> 0.05) vary between the control and experimental rats following administration of*C. excavata*extract ([Table 6](#tab6){ref-type="table"}).

3.7. Histopathology {#sec3.7}
-------------------

Microscopic evaluation of tissue sections of M1 and M2 rats did not show abnormal histopathological changes. However, kidney sections of F1 and F2 rats showed histopathological changes that varied according to dose level. These changes include mild tubular epithelial degeneration, increased bowman\'s capsular space as a result of constriction of the glomerulus, mild congestion, cast-like materials within the renal tubular spaces, and mild leukocytic infiltration typified by lymphocyte, and neutrophil infiltration in the renal interstitium ([Figure 3](#fig3){ref-type="fig"}).

Microscopic examination of the liver sections of M1, F1 and M2, F2 rats showed central vein congestion, cloudy hepatocytes swelling, and diffuse infiltration by Kupffer cells. Multifocal areas of mild perilobular necrosis coupled with neutrophil infiltration were observed in some sections of the liver tissue of the male rats given a high dose of extract, indicating that the effect of the high dose MECE leaves was more severe in the male than female rats ([Figure 4](#fig4){ref-type="fig"}).

4. Discussion {#sec4}
=============

Over the past years, a handful of pharmacologically active constituents of plants belonging to the family Rutaceae have been identified, these include methoxyflavones, furoquinoline alkaloids, furanone-coumarins, and flavonoids. These constituents were shown to have vital effects on inflammation, viral infections, and digestive system disorders such as gastritis and enteritis \[[@B32]--[@B44]\]. Phytochemical screening showed that these plants contain furanone-coumarins, flavonoids, and glycosides \[[@B46], [@B48]\].*C. excavata*, in particular, possesses a wide range of pharmacological properties which range from antioxidant properties \[[@B12]\], hyperglycemic, anti-rhinitis, anti-inflammatory \[[@B38]\], anti-nociceptive \[[@B35]\], anti-viral, anti-cancer and anti-fungal activities \[[@B22], [@B40]\]. To determine the antioxidant activities of*C. excavata*, most of these studies used the bark and stem of the plant, not the leaves. In the present study, the MECE leaves were observed to strongly reduce FeCl~3~ and showed the scavenging activity for DPPH, at potency close to that of quercetin. This observation suggests that the*C. excavata* extract, by its phenolic and flavonoid contents, may be able to donate electrons to the free radicals \[[@B30], [@B18]\]. It is well-documented that phenolic compounds are among principal and effective antioxidant constituents in plant foods \[[@B43]\]. Thus quantification of phenolic contents of an extract would be essential to determine its antioxidant activity. Previous studies have reported that MECE leaves with high phenolic content inhibit lipid peroxidation \[[@B12], [@B38]\]. Flavonoids of the MECE leaves with their wide spectrum of medicinal actions are the major polyphenols in the scavenging of oxidizing species like hydroxyl radical, superoxide anion, or peroxyl radicals \[[@B14]\] (Alnajar et al., 2012). The chloroform extract of*C. excavata*was shown in the current study to have the highest concentration of flavonoids, which is comparable with those reported by others \[[@B16], [@B11]\]. Thus it is not surprising that*C. excavata*, with its potent phenolic antioxidant, is effective in the treatment of various oxidative stress-related chronic diseases.

The MECE leaves showed good antioxidant activity and were subsequently selected for phytochemical screening and animal studies. Initial investigation using LCMS/MS confirmed that the MECE leaves are rich in phenolic/flavonoids-based compounds \[[@B17]\]. Notably, these compounds in the MECE leaves possess several biological activities; for example, coumarin has been used as an anti-inflammatory, anticholinesterase, antioxidant, and anticancer compound \[[@B32], [@B44], [@B28]\]; quercetin glycoside has been used as a hepatoprotective compound in CCl~4~-induced hepatic damage, while kaempferol and myricetin glucosides have been shown to have high anti-inflammatory and antioxidant activities \[[@B7], [@B21]\].

The toxicity of MECE leaves in rats was evaluated by an acute 14-day study. No mortality or symptom of toxicity was observed in the rats in the study. The LD50 of MECE leaves in both sexes of rats were greater than 5000 mg/kg body weight. This is in accordance with an earlier study \[[@B34]\], which reported that oral LD50 of the methanolic extract from the stem of*C. excavata* is more than 5000 mg/kg body weight in both sexes in rats. Therefore, the high LD50 of MECE leaves indicates that the extract is relatively safe, especially for oral administration. According to Ecobichon \[[@B10]\] and OECD, any test compound that does not produce adverse effects at a dose exceeding 5 g/kg body weight is considered nontoxic.

Change in body weight and relative organ weight of animals is an indicator of adverse effect of administered drugs or chemicals \[[@B42], [@B29]\]. The organs of these animals tend to swell or become damaged, which will subsequently alter their organ-to-body weight ratios upon exposure to toxic substances. In this study, the body weights of rats (male and female) treated with MECE leaves increased gradually but insignificantly (*P* \> 0.05) compared with the control rats. Similarly, the relative organ weights showed no significant (*P* \> 0.05) difference between test and control groups.

Increased serum creatinine is a good indicator of abnormal kidney function while simultaneous increases in serum AST and ALT concentrations are associated with hepatopathy \[[@B37]\]. Our study showed significant (*P* \< 0.05) but variable increases in serum enzymes in male and female rats treated with MECE leaves. Serum bilirubin concentration was significantly (*P* \< 0.05) elevated in MECE leaves-treated female rats only. In this case, increase in ALP level is associated with increased hepatic synthesis, in the presence of increasing biliary pressure and obstruction in the normal bile flow as a result of damage or inflammation \[[@B11]\]. In male rats treated with low dose MECE leaves, we observed that the serum bilirubin and ALP concentrations were not significantly (*P* \> 0.05) different from that of the controls, an indication that the liver has not been compromised by the treatment.

Significant increase in BUN without abnormality in serum creatinine concentration in female rats treated with a high dose MECE leaves is indicative of hemoconcentration and/or high dietary protein rather than kidney impairment \[[@B3], [@B4]\]. This assertion is based on the fact that serum creatinine is a more accurate marker of glomerular filtration and kidney function than urea. Serum Na^+^ was slightly elevated in both treated male and female rats, while K^+^ was elevated in the male rats only and Cl^−^ in female rats treated with high dose MECE leaves only. Since the concentrations of these electrolytes in blood are generally governed by diet and water intake, these changes do not reflect adverse effect of MECE leaves.

Although MECE leaves-treatment of rats produced mild to moderate pathological changes in the kidneys and liver, neither mortality nor symptoms of toxicity at the doses used in this study were observed; thus the extract is presumed safe for oral application.

5. Conclusion {#sec5}
=============

The MECE leaves contain pharmacologically active compounds including flavonoids and phenolics, which are good antioxidants. The MECE leaves did not exhibit obvious toxicity at concentrations even at a high dose of 5000 mg/kg body weight. Thus the MECE leaves have potent antioxidant activity and are presumed safe to be used orally as health-promoting product at low to moderate doses.
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![Ferric-reducing antioxidant power of*Clausena excavata*extracts in solvents MOH = methanol; EA = ethyl acetate; CH = chloroform; PT = petroleum ether.](ECAM2014-975450.001){#fig1}

![Scavenging activity of*Clausena excavata*extracts on DPPH radical. MOH = methanol; EA = ethyl acetate; CH = chloroform; PT = petroleum ether.](ECAM2014-975450.002){#fig2}

![Kidney after treatment with methanolic extract of*Clausena excavata*. (a) and (b) Kidney (control; male and female) showing normal glomeruli (G) and tubules (T) in the cortex region. (c) and (d) Kidney (low dose; 2000 mg/kg, male and female rats) showing tubular degeneration and mild mononuclear cell infiltration (arrows). (e) and (f) Kidney (high dose; 5000 mg/kg, male amd female rats) showing presence of cast in the tubular lumen and mild tubular degeneration (H&E, ×200).](ECAM2014-975450.003){#fig3}

![Liver treated with methanolic extract of*Clausena excavata*. (a) and (b) Normal hepatocytes, parenchyma, and central vein, respectively. (c) and (d) Liver (low dose; 2000 mg/kg, male and female rats) showing mononuclear cell infiltrations and congestion of the central vein (arrows). (e) and (f) Liver (high dose; 5000 mg/kg, male and female rats) showing infiltration of kupffer cells, vascular congestion, and mild periportal necrosis. (H&E, ×200).](ECAM2014-975450.004){#fig4}

###### 

Total phenolic and flavonoid contents of *Clausena excavata* extracts.

  Extract content          Solvent                                             
  ------------------------ ----------------- ---------------- ---------------- ----------------
  TPC (mg GAE/g extract)   522.0^a^ ± 11.6   497.0^b^ ± 7.1   373.0^c^ ± 6.9   157.0^d^ ± 7.5
  TFC (mg QE/g extract)    96.7^c^ ± 2.0     142.5^b^ ± 1.0   188.6^a^ ± 3.0   25.8^d^ ± 0.8

Values are mean ± SD.

^a,b,c,d^Mean ± SD with different superscripts are significantly different at *P* \< 0.05.

TPC = total phenolic content; TFC = total flavonoid content; GAE = Gallic acid equivalent; QE = quercetin equivalent.

###### 

Compound identified from MECE via LCMS/MS analysis.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Retention time   Molecular weight   MS/MS fragments ions \                                                                                                                                                                                                                 Tentative Identification                           References
                                      \[M − H\]^−^, \[M + H\]^+^                                                                                                                                                                                                                                                                
  ---------------- ------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------- -------------------------------------
  3.69             756.2              (−) 755, 300, 271.0, 255.1, 179.0, 151.0                                                                                                                                                                                               Quercetin-rhamnose-hexose-rhamnose                 Chua et al., 2011 \[[@B8]\] \
                                                                                                                                                                                                                                                                                                                                Kachlicki et al., 2008 \[[@B19]\] \
                                                                                                                                                                                                                                                                                                                                Del Rio et al., 2004 \[[@B9]\]

                                                                                                                                                                                                                                                                                                                                

  3.9              772.2              (−) 771, 316, 271.1, 179.0, 151.0                                                                                                                                                                                                      Myricetin glucoside \                              Chua et al., 2011 \[[@B8]\] \
                                                                                                                                                                                                                                                                             Conjugate \                                        Kachlicki et al., 2008 \[[@B19]\] \
                                                                                                                                                                                                                                                                             Myricetin 3-O-rhamnosyl-glucoside 7-O-rhamnoside   Del Rio et al., 2004 \[[@B9]\]

                                                                                                                                                                                                                                                                                                                                

  4.3              740.2              (−) 739.2, 284.1, 255.0, 179, 151.0, 179.0,                                                                                                                                                                                            Kaempferol conjugate                               Chua et al., 2011 \[[@B8]\] \
                                                                                                                                                                                                                                                                                                                                Zhao et al., 2011 \[[@B47]\]

                                                                                                                                                                                                                                                                                                                                

  7                179.3              (+) 161.2, 135.1, 133.1                                                                                                                                                                                                                Caffeic acid                                       Chua et al., 2011 \[[@B8]\]

                                                                                                                                                                                                                                                                                                                                

  6.72                                (+) 77.0, 91.0, 95.0, 105.0, 119.1, 134.1, 148.3, 149.2, 156.3, 161.3, 174.4, 177.3, 179.3, 190.4, 202.4, 204.4, 206.4, 218.4, 221.4, 230.4, 232.4, 243.4, 245.4, 246.4, 256.4, 270.4, 284.4, 288.4, 298.4, 316.4, 326.4, 344.4, 362   8-Geranyloxy psoralen                               

                                                                                                                                                                                                                                                                                                                                

  5.95                                (+) 77.91, 91.0, 95.0, 111.0, 119.0, 133.1, 147.2, 149.2, 161.2, 177.2, 179.3, 191.3, 203.3, 243.3, 245.4, 247.3, 255.3, 271.4, 273.4, 289.4, 291.4, 313.4, 323.4, 331.4, 341.4, 359.4, 377.4                                          Unidentified furocoumarin                           

                                                                                                                                                                                                                                                                                                                                

  5.27                                (+) 117.1, 134.2, 146.2, 147.2, 150.2, 160.3, 163.3, 180.3, 202.3, 246.4, 473.4, 491.5, 509.5, 527.6                                                                                                                                   Unidentified flavonoids                             

                                                                                                                                                                                                                                                                                                                                

  5.5                                 (+) 119.0, 134.1, 146.2, 147.2, 162.3, 164.3, 180.3, 201.3, 229.3, 245.3, 240.4, 246.4, 294.4, 341.3, 404.4, 491.4, 523.3, 531.5, 541.6, 559.6                                                                                         Unidentified flavonoids                             

                                                                                                                                                                                                                                                                                                                                

  6.2                                 (+) 146.2, 179.3, 194.4, 203.3, 247.3, 292.4, 324.4, 324.4, 370.4, 388.4, 470.4, 557.6, 735.7                                                                                                                                          Unidentified flavonoids                             

                                                                                                                                                                                                                                                                                                                                

  4.72                                (−) 107.0, 123.0, 137.1, 139.1, 163.1, 179.1, 195.2, 197.2, 241.1                                                                                                                                                                      Unidentified phenolic acid                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Relative weights of selected organs after administration of a single dose methanolic extract of *Clausena excavata*.

  Organ    Sex           MECE treatment (mg/kg body weight)                 
  -------- ------------- ------------------------------------ ------------- -------------
  Liver    Male          2.33 ± 0.10                          2.55 ± 0.19   2.58 ± 0.20
  Female   2.60 ± 0.07   2.78 ± 0.14                          2.82 ± 0.16   
                                                                            
  Kidney   Male          0.68 ± 0.01                          0.74 ± 0.02   0.70 ± 0.01
  Female   0.55 ± 0.01   0.61 ± 0.02                          0.63 ± 0.03   

Values are mean ± SD.

MECE = methanolic extract *Clausena excavata*; untreated = rats given normal diet.

###### 

Effect of methanolic extract of *Clausena excavata*extract on liver biochemical parameters.

  ------------------------------------------------------------------------------------------------------------------
  Treatment group \       ALT \           AST \             ALP \             Albumin \       Bilirubin (*µ*mol/L)
  (MECE leaves)           (U/I)           (U/I)             (U/I)             (g/dL)          
  ----------------------- --------------- ----------------- ----------------- --------------- ----------------------
  Male                                                                                         

   CM                     57.0^a^ ± 2.2   196.0^a^ ± 3.6    177.7^a^ ± 7.5    12.2^a^ ± 0.3   2.19^a^ ± 0.01

   M1 (2000 mg/kg b.wt)   59.1^a^ ± 2.3   183.4^a^ ± 11.7   228.2^b^ ± 27.0   13.0^b^ ± 0.3   2.73^b^ ± 0.17

   M2 (5000 mg/kg b.wt)   64.7^b^ ± 4.3   256.6^b^ ± 20.4   248.6^b^ ± 23.4   13.8^b^ ± 0.3   2.42^a^ ± 0.22

  Female                                                                                       

   CF                     46.8^a^ ± 2.5   165.1^a^ ± 6.2    143.3^a^ ± 10.7   14.7^a^ ± 0.7   1.92^a^ ± 0.03

   F1 (2000 mg/kg b.wt)   47.8^a^ ± 2.1   181.6^a^ ± 15.9   109.0^b^ ± 5.2    15.2^a^ ± 0.2   2.76^b^ ± 0.19

   F2 (5000 mg/kg b.wt)   53.7^b^ ± 5.2   195.1^a^ ± 26.4   193.2^c^ ± 19.3   14.8^a^ ± 0.3   2.83^b^ ± 0.16
  ------------------------------------------------------------------------------------------------------------------

Values are mean ± SD.

^a,b,c^For each sex, means within column with different superscript are significant at *P* \< 0.05.

ALT = alanine transaminase; AST = aspartate transaminase; ALP = alkaline phosphatase.

MECE = methanolic extract *Clausena excavata*; CM = untreated control male; CF = untreated control female; M1, M2, F1, and F2 are treatment groups; b.wt = body weight.

###### 

Effects of methanolic extract of *Clausena excavata*on kidney biochemical parameters.

  --------------------------------------------------------------------------------------------------------------
  Treatment Group \       Sodium \          Potassium \      Chloride \       Urea \           Creatinine \
  (MECE leaves)           (mmol/L)          (mmol/L)         (mmol/L)         (mmol/L)         (umol/L)
  ----------------------- ----------------- ---------------- ---------------- ---------------- -----------------
  Male                                                                                          

   CM                     144.31^a^ ± 0.7   4.90^a^ ± 0.10   104.8^a^ ± 0.1   6.42^a^ ± 0.34   635.6^a^ ± 21.4

   M1 (2000 mg/kg b.wt)   145.8^b^ ± 0.2    4.66^b^ ± 0.06   103.6^b^ ± 1.0   4.61^b^ ± 0.21   379.6^b^ ± 48.7

   M2 (5000 mg/kg b.wt)   146.2^b^ ± 0.4    5.00^b^ ± 0.25   105.0^a^ ± 0.4   5.90^c^ ± 0.21   415.5^b^ ± 25.7

  Female                                                                                        

   CF                     144.4^a^ ± 0.7    4.70^a^ ± 0.06   104.3^a^ ± 1.1   5.79^a^ ± 0.17   576.8^a^ ± 31.1

   F1 (2000 mg/kg b.wt)   144.2^b^ ± 0.7    4.64^a^ ± 0.29   104.4^a^ ± 0.4   5.81^a^ ± 0.24   424.6^b^ ± 19.3

   F2 (5000 mg/kg b.wt)   146.1^b^ ± 0.9    4.90^a^ ± 0.15   106.8^b^ ± 0.6   7.70^b^ ± 0.29   561.6^a^ ± 29.8
  --------------------------------------------------------------------------------------------------------------

Values are mean ± SD.

^a,b,c^For each sex, means within column with different superscript are significant at *P* \< 0.05.

MECE = methanolic extract *Clausena excavata*; CM = untreated control male; CF = untreated control female; M1, M2, F1, and F2 are treatment groups; b.wt = body weight.

###### 

Effects of methanolic extract of *Clausena excavata*extract on hematological parameters in rats.

  Parameter                Sex            MECE leaves treatment (mg/kg body weight)                  
  ------------------------ -------------- ------------------------------------------- -------------- --------------
  Erythrocyte (10^12^/L)   Male           8.44 ± 0.11                                 8.04 ± 29.00   8.32 ± 0.20
  Female                   7.80 ± 0.03    7.79 ± 0.03                                 7.77 ± 0.02    
                                                                                                     
  Leukocyte (10^9^/L)      Male           8.46 ± 0.21                                 9.94 ± 0.37    9.62 ± 0.10
  Female                   6.55 ± 0.96    6.20 ± 0.71                                 6.13 ± 0.34    
                                                                                                     
  Hemoglobin (g/L)         Male           13.80 ± 0.20                                14.02 ± 0.31   13.40 ± 0.07
  Female                   13.10 ± 0.12   12.63 ± 0.48                                12.50 ± 0.27   

Values are mean ± SD.

MECE = methanolic extract *Clausena excavata*; untreated = rats given normal diet without MECE leaves treatment.

[^1]: Academic Editor: Wenyi Kang
